The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail

Zerofen 2.5% Oral Suspension

2.5 percent weight/volume Oral suspension

Chanelle Pharmaceuticals Manufacturing LimitedVPA10987/017/002

Main Information

Trade NameZerofen 2.5% Oral Suspension
Active SubstancesFenbendazole
Strength2.5 percent weight/volume
Dosage FormOral suspension
Licence HolderChanelle Pharmaceuticals Manufacturing Limited
Licence NumberVPA10987/017/002

Group Information

ATC CodeQP52AC13 fenbendazole
Therapeutic ClassEndoparasiticide


Licence Issued05/08/1992
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation


Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
« Back